HughesGR. The antiphospholipid syndrome: Ten years on. Lancet1993; 342: 341–344.
2.
Ruiz-IrastorzaGKhamashtaMAHughesGR. Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome. Lupus2001; 10: 241–245. Review.
3.
AshersonRACerveraR. ‘Primary,’ ‘secondary’ and other variants of the antiphospholipid syndrome. Lupus1994; 3: 293–298.
4.
TriplettDA. Assays for detection of antiphospholipid antibodies. Lupus1994; 3: 281–287.
5.
BerteroMTBazzanMCarignolaR. Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. Lupus2012; 21: 806–809.
6.
Ruiz-IrastorzaGCuadradoMJRuiz-ArruzaI. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus2011; 11: 206–218.
7.
Alarcón-SegoviaDBoffaMCBranchW. Prophylaxis of the Antiphospholipid Syndrome: A Consensus Report. Lupus2003; 12: 499–503.
8.
TincaniABranchWLevyRA. Treatment of pregnant patients with antiphospholipid syndrome. Lupus2003; 12: 524–529.
